Brian Sherman has been a Director of the company since inception in 1987. He was appointed Chairman on 20 February 2004 and brings to the position his considerable experience gained in both funds management and stockbroking, as well as general commercial fields of endeavour.
He was chairman and joint managing director of the fund management company EquitiLink, a director of SOCOG and chair of its finance committee and a director of Channel 10 for some 16 years.
Mr Sherman was appointed as a member of the Order of Australia in 2004 for his service to the community as a philanthropist and benefactor to arts, education and sporting organisations, and to business and commerce. Mr Sherman was the winner of the Ernst & Young Eastern Region Champion of Entrepreneurship 2006 and in 2009 was awarded an Honorary Doctor of Letters (HonLittD) from the University of Technology Sydney (UTS) for his significant philanthropic support for the community.
Director since 1987.
Barry Sechos has over 25 years experience as a director, business executive and corporate lawyer. Barry is a Director of the Sherman Group Pty Limited, a privately owned investment company located in Sydney, Australia. Barry is also a director of Paddington St Finance Pty Limited, a specialist structured finance company; See-Saw Films, an Australian and UK based film production and finance group and winner of the 2011 Academy Award for Best Picture for The King’s Speech; Transmission Films, an Australian film distribution company. Barry is Non-Executive Chairman of Regeneus Limited, an Australian based regenerative medicine company listed on the Australian Securities Exchange which focuses on using the regenerative capacities of stem cells to develop innovative cell therapies for humans and animals. He is a member of the Audit Committee and Risk and Compliance Committee.
Director since 2013.
John has served as an independent non-executive director of the company since 2017. He has over 20 years of experience as a company director and business executive having served as CEO of ASX-listed Babcock & Brown Communities Group, Primelife and Regeneus. John is a former corporate and executive partner of law firm Allens where he specialised in M&A, fundraising and corporate advisory. He is a non-executive director of ASX-listed Access Innovation Media, national law firm, Sparke Helmore and technology companies, BioPoint and Lokket. John is the chairman of the Audit Committee and member of the Risk and Compliance Committee.
Director since 2017.
David is the Chief Executive Officer and Chief Investment Officer of Carrara Investment Management, the underlying investment manager of CLF. David took on this role in July 2020, having previously served as Chief Executive Officer and Chief Investment Officer of CLF from January 2018 to June 2020. He was appointed to the board of CLF in May 2018. David has a PhD in Applied Finance and over 15 years of investment management experience both domestically and internationally. Prior to joining CLF, David was Chief Investment Officer at Crestone Wealth Management, which was spun out of UBS Wealth Management Australia, where he was Head of Investment Strategy. David was previously a senior analyst and trader for a US-based global macro hedge fund, which managed capital for US institutions and high net worth individuals. He is a member of the Audit Committee.
Director since 2018.